E
Keros Therapeutics, Inc. KROS
$11.58 $0.110.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 2,027.27% 4,750.00% -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 2,027.27% 4,750.00% -- -- --
Cost of Revenue -31.09% 44.19% 24.53% 23.05% -436.52%
Gross Profit 34.50% -43.08% -24.42% -22.78% 437.10%
SG&A Expenses 17.13% 7.35% 13.15% 32.53% 28.37%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.81% 36.40% 22.11% 24.95% 45.80%
Operating Income -14.64% -35.53% -22.02% -24.73% -45.35%
Income Before Tax -13.62% -34.27% -20.67% -20.42% -35.42%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -14.37% -34.27% -20.67% -20.42% -35.42%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -14.37% -34.27% -20.67% -20.42% -35.42%
EBIT -14.64% -35.53% -22.02% -24.73% -45.35%
EBITDA -14.53% -35.46% -21.84% -24.56% -45.16%
EPS Basic 14.58% -5.97% 1.07% 4.27% -22.83%
Normalized Basic EPS 15.14% -5.97% 1.05% 4.27% -22.83%
EPS Diluted 14.58% -5.99% 1.07% 4.27% -22.83%
Normalized Diluted EPS 15.14% -5.97% 1.05% 4.27% -22.83%
Average Basic Shares Outstanding 33.89% 26.70% 21.96% 25.79% 10.25%
Average Diluted Shares Outstanding 33.89% 26.70% 21.96% 25.79% 10.25%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings